Our Physicians Our Team Approach Clinical Trials Clinical Trials Overview Frequently Asked Questions HCI Clinical Trials List For More Information Cancer Registry Clinical Trials Protocol No. All patients must have a biopsy proven diagnosis of low, intermediate or high grade malignant non-Hodgkin's lymphoma. Transformed lymphomas are eligible. Patients must have relapsed after achieving a complete or partial response to prior therapy, or have never responded to prior therapy.
Prior therapy is required.
Concurrent therapy is NOT permitted. If the patient has had one or more CR, then the most recent CR must have been less than one year in duration. Patients must have a bone marrow aspirate and biopsy obtained within 42 days prior to registration. Patients with a history of seizures or central nervous system involvement by lymphoma are NOT eligible. Only patients with a normal cardiac history and physical exam or in lieu of this, an institutionally normal ejection fraction as measured by either ECHO or MUGA scan are eligible.